• Explore /
  • Poster
  • / A randomised phase II clinical trial of low-dose cyclophosphamide and transarterial chemoembolization (TACE) with or without vaccination with dendritic cells (DC) pulsed with HepG2 lysate ex vivo in patients with hepatocellular carcinoma (HCC): The ImmunoTACE trial.

A randomised phase II clinical trial of low-dose cyclophosphamide and transarterial chemoembolization (TACE) with or without vaccination with dendritic cells (DC) pulsed with HepG2 lysate ex vivo in patients with hepatocellular carcinoma (HCC): The ImmunoTACE trial.

Abstract Poster

Authors

null

Yuk Ting Ma

University of Birmingham, Birmingham, United Kingdom

Yuk Ting Ma , Amanda Kirkham , Stuart Curbishley , Anna Rowe , Miroslava Blahova , Homoyon Mehrzad , Salil Karkhanis , Pankaj Punia , Martin James , Ankit Rohit Rao , Nick Stern , Daniel H. Palmer , Diana Hull , Faye Lowe , Jessica Douglas-Pugh , Camilla Bathurst , Manpreet Wilkhu , Christina Yap , David H Adams

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

11889464

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 4012)

DOI

10.1200/JCO.2022.40.16_suppl.4012

Abstract #

4012

Poster Bd #

1

Abstract Disclosures

Similar Posters

First Author: Daniela Annenelie Bota

First Author: Mingyue Cai

First Author: Masatoshi Kudo

First Author: José María López-Picazo